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Abstract 
Background: Recognition of association between anemia and new onset atrial fibrillation would result in better 
therapeutic approaches and better prognosis. Hence, the purpose was to determine the prevalence of anemia and 
new onset atrial fibrillation (AF) in patient come to Imam Hossein hospital emergency department. 
Materials and Methods: In the observational study that performed as a case-control survey, 150 consecutive 
addicted patients in imam hossein hospital emergency department in 2018 were enrolled including those with 
and without AF in electrocardiogram (EKG) and the frequency rate of anemia among groups was determined 
and compared. 
Results: The results in this study demonstrated that 43 patients (27.8%) had anemia that was seen in 36% and 
21.3% in case and control groups, respectively with statistically significant difference (p=0.047). 
Conclusion: Totally, according to the obtained results there was significant association between anemia and new 
onset atrial fibrillation.  
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Introduction 
Atrial fibrillation (AF) is a common cardiac 
arrhythmia with prevalence range of 0.1 to 4 percent 
in general population and 2.8 to 14 percent among 
admitted patients1. The prevalence is raised with age2 
with total prevalence rate of 2.1 percent3. However 
there is increasing trend in current years with 2.5-fold 
increase2,4 with some ethnic differences5. The 
prevalence may rise to nine percent in high-elderly 
period6. It is accompanied with high rate of 
myocardial infarction with five-fold increase that is 
more lethal with higher costs6-8. AF is the most 
common cardiac arrhythmia among adults9,10. Since 
AF and anemia may be increased with age and both are 
accompanied with high morbidity and mortality rate 
recognition of anemia as risk factors for new onset AF 
is important. Regarding the increasing rate with age11,12 
and increased elderly ratio in communities13 AF should 
receive further attention especially among men and 
white race subjects14. AF is accompanied with two-fold 
higher mortality rate15 and there are some risk factors 
such as atrial ischemia, inflammation, drugs16,17. On the 
other hand, anemia is also common and seen in nearly 
one-fourth in general population18. It is risk factor for 
cardiac ischemia and failure19-21. Simultaneous 
presence of AF and anemia would result in further 
background diseases22 and anemia is dependently 
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accompanied with higher mortality rate23. 
Recognition of association between anemia and new 
onset atrial fibrillation would result in better 
therapeutic approaches24 and better prognosis. Hence, 
the purpose was to determine the prevalence of anemia 
and new onset atrial fibrillation in patient come to 
imam hossein hospital emergency department. 
Methods 
In the observational study that performed as a case-
control survey, 150 consecutive addicted patients in 
imam hossein hospital emergency department in 2018 
were enrolled including those with and without AF in 
electrocardiogram (EKG or ECG). The inclusion 
criteria were new-onset AF in case and lack of it in 
control group. In addition, the exclusion criteria were 
congestive heart failure (CHF) in echocardiography, 
hypothyroidism, cardiomyopathy, active ischemia, 
hypertension, obesity, chronic obstructive pulmonary 
disease (COPD), and acute anemia due to bleeding 
and hemolysis.  
Patients were two groups of 75 subjects that were 
enrolled after signing the informed consent form were 
assessed by ECG and new onset AF cases underwent 
echocardiography and if had no exclusion criteria 
were enrolled. Then complete blood count (CBC) was 
assessed and the frequency rate of anemia among 
groups was determined and compared. It was 
according to the WHO definition (Hb less than 14 and 
12 g/dl in men and women, respectively). Also the 
type was assessed according to B12, folate, ferritin, 
TIBC, and SI. 
Data analysis was dome by SPSS version 20.0 
software. The mean and standard deviation were 
determined for numerical variables and frequency and 
percent were measured for categorical ones. The used 
tests were Independent-Sample-T, Chi-Square, and 
odds ratio with significance level of less than 0.05. 
Results 
The age and gender were alike across the groups 
(Table 1) with male frequency of 47 and 42 in case 
and control groups, respectively. The results in this 
study demonstrated that 43 patients (27.8%) had 
anemia that was seen in 36% and 21.3% in case and 
control groups, respectively with statistically 
significant difference (P=0.047). 
There was significant association for men but not for 
women (Table 2). As shown in Table 3, there was no 
significant difference between AF and hemoglobin 
level (p>0.05). However it was seen in men (p=0.004) 
but not women (p>0.05). 
The anemia type was iron-deficiency, chronic-disease, 
and megaloblastic type in 43, 29, and 13 cases. Type of 
anemia was not related to AF and age (p>0.05) and it 
was not related to gender in AF group but in control 
group (p=0.017) with higher iron-deficiency anemia 
among females. In addition, the anemia was related to 
gender in control group (p=0.006) and it was higher in 
females. Age was not related to anemia (p>0.05). The 
anemia was subdivided into groups of mild (Hb of 12-
14), moderate (Hb of 10-12), and severe (Hb<10). As 
shown in Table 4, the severity was differed between 
groups in male subjects. However, it was not differed 
among females as well as total population (p>0.05). 
Discussion 
In this case-control study, it was seen that nearly 28 
percent had anemia that had higher frequency rate 
among AF cases. Lack of association between age and 
anemia in this study may be due to exclusion of cases 
with acute and lethal conditions. It is the power of our 
study and a novelty in current paper that would result in 
higher specificity beside the association of anemia 
severity and AF. The association of anemia severity 
with AF was significant in men and non-significant in 
women that may be due to tolerance of physiological 
anemia among women during the life. However totally 
the AF and anemia severity were not related that was 
unexpected because the male predominance was 
present in this study. 
Lakkireddi et al25 reported possible significant 
etiological association between AF and anemia and 
necessity for further studies as well as our paper. In 
addition, Ganga et al26 reported rates of 7.5% and 5.5% 
for AF in those with and without anemia that showed 
no association between anemia and AF among elderly 
subjects. However, we had different results due to wider 
studied age range. The study by Xu et al27 reported 1.5-
fole increased risk for new-onset AF in patients with 
anemia as seen in our study. 
Keskin et al28 reported higher rate of iron deficiency 
anemia among cases with new-onset AF but not those 
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due to folate or B12 deficiency. However, in current 
study the type of anemia was not differed between 
case and control groups, respectively. Hu et al29 
reported higher AF rate in patients with aplastic 
anemia. However, none of the patients in our study 
had aplastic anemia. Study by Lin et al30 demonstrated 
that anemia in AF cases may be due to used drugs such 
as digoxin. However, the drug history in our study was 
negative. 
Conclusion 
Totally, according to the obtained results it may be 
concluded that there is significant association between 
anemia and new onset atrial fibrillation. Hence, 
treatment of anemia would result in decreased rate of 
AF and subsequent problems. However, further 
studies with larger sample size and multi-center 
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